Reliability in life sciences logistics: What good looks like

Reliability has always been a fundamental requirement in life sciences logistics. However, what constitutes a reliable supply chain is changing rapidly. As pharmaceutical manufacturing, clinical trials, and laboratory networks become more global and interconnected, reliability can no longer be defined simply by whether a shipment arrives on time.

Today, organisations transporting clinical trial materials, biological samples, cell and gene therapies, and temperature-sensitive medicines face an increasingly complex operating environment. Regulatory requirements continue to evolve, transportation networks face periodic disruption, and many products being shipped are more sensitive than ever before. In this environment, reliability has become a broader concept encompassing visibility, risk management, compliance, communication, and resilience.

Why reliability is being redefined

For many years, on-time delivery rates were the primary benchmark for logistics performance. While delivery schedules remain important, they provide only a partial view of shipment success.

A shipment may arrive within the planned timeframe, but still experience a temperature excursion, documentation error, customs delay, or compliance issue that compromises product integrity or usability. For highly sensitive biological materials and advanced therapies, such incidents can have significant consequences, potentially affecting research programmes, clinical trials, or patient treatment schedules.

At the same time, life sciences supply chains have become increasingly international. Manufacturing, research, testing, and treatment often take place across multiple countries and regulatory jurisdictions. This expanded network introduces additional complexity, requiring greater coordination between manufacturers, contract research organisations, laboratories, clinical sites, and logistics providers.

As a result, organisations are placing increased emphasis on proactive supply chain management and the ability to anticipate and mitigate risks before they affect shipment outcomes.

The key pillars of modern logistics reliability

Reliable logistics performance today is built upon several interconnected capabilities.

Proactive risk management

Effective reliability starts long before a shipment is collected. Route assessments, lane monitoring, country specific regulations, and risk evaluations help identify potential vulnerabilities such as weather disruptions, customs bottlenecks, infrastructure challenges, or capacity constraints.

Rather than reacting to problems after they occur, leading organisations increasingly focus on developing mitigation strategies in advance. Alternative routing options, pre-approved contingency plans, and ongoing network monitoring help reduce disruption and improve shipment continuity.

Visibility and control

Real-time visibility has become a critical component of logistics reliability, particularly for high-value and time-sensitive shipments such as cell and gene therapies. Modern monitoring technologies enable organisations to track not only shipment location, but also temperature and other environmental conditions throughout transit. This transparency allows for rapid intervention when conditions move outside acceptable parameters, helping to protect product integrity and minimise the risk of loss.

However, visibility extends beyond tracking data alone. For critical shipments, it also requires continuous oversight and responsive after-hours support. When a planned shipment milestone is missed, clients need immediate answers on what has happened and what actions are being taken, rather than waiting until the next business day. In sectors where delays can have direct implications for patient treatment, timely communication and proactive issue resolution are essential. Combined with real-time monitoring, around-the-clock support ensures stakeholders remain informed and confident throughout the shipment journey.

Regulatory compliance

Compliance remains a critical aspect of reliable logistics operations.

Life sciences products often move through multiple regulatory environments, each with specific documentation, import/export requirements, and Good Distribution Practice (GDP) expectations. Consistently maintaining compliance across jurisdictions requires both expertise and robust operational processes.

From customs documentation to chain-of-custody management, reliability depends on ensuring shipments meet regulatory obligations at every stage.

Communication and collaboration

Even the best logistics plans can be tested by unexpected events. When disruptions occur, clear and proactive communication becomes essential. Effective coordination between manufacturers, clinical sites, laboratories, and logistics providers supports faster decision-making and more efficient issue resolution.

Just as importantly, strong communication gives clients peace of mind. When an issue arises, they need to know that the situation has been identified, assessed, and is actively being managed. Timely updates provide stakeholders with the information they need to evaluate risks, make informed decisions, and implement corrective actions quickly.

Silence can be as damaging as the disruption itself. Even when teams are working behind the scenes to resolve a problem, a lack of communication leaves clients questioning what is happening and whether the shipment is receiving the attention it requires. Keeping stakeholders informed every step of the way builds trust, maintains confidence, and often determines whether a minor issue remains manageable or escalates into a significant operational challenge.

Contingency planning

Reliability is ultimately measured not only by preventing disruptions, but by responding effectively when they occur.

Organisations with established escalation procedures, recovery plans, and alternative transportation solutions are better positioned to minimise impacts on critical shipments. Preparation allows supply chains to remain resilient even in the face of unforeseen challenges.

Measuring what matters

As expectations evolve, so too must the metrics used to assess logistics performance.

On-time delivery remains a valuable indicator, but it should be considered alongside a wider range of performance measures. Temperature compliance, shipment integrity, deviation rates, and exception management outcomes all offer important insight into operational reliability.

Organisations are also paying closer attention to response times, communication effectiveness, and the ability to proactively identify and resolve emerging issues. The availability of real-time shipment visibility, combined with timely and accurate documentation, provides a more complete picture of logistics performance than delivery metrics alone.

Effective issue management depends on clearly recording what has happened, what actions will be taken next, who is responsible, and when follow-up will occur. While these updates may not always be visible to clients, robust internal documentation ensures teams can act quickly, maintain continuity, and keep stakeholders informed. This structured approach reduces reliance on lengthy email chains and fragmented communications, helping organisations resolve issues more efficiently and consistently.

Ultimately, the most meaningful reliability measure is whether products reach patients, laboratories, and clinical sites safely, compliantly, and fit for purpose.

How technology is strengthening reliability

Technological innovation is playing an increasingly important role in supporting reliable supply chains and navigating the complexities of global logistics, including recent developments in artificial intelligence (AI).

Real-time monitoring platforms and IoT-enabled tracking solutions provide continuous insight into shipment status and environmental conditions, helping organisations scale operations, improve efficiency, and respond more effectively to emerging risks. Predictive analytics can support earlier intervention and more informed planning, while enhanced visibility enables logistics teams to make faster, data-driven decisions across transportation and storage activities.

However, technology alone does not guarantee reliability. Life sciences logistics extends far beyond collecting, transporting, and delivering a shipment. It requires continuous communication, regulatory oversight, document review, chain of custody management, and proactive monitoring. As regulations evolve and medical breakthroughs reshape the industry, logistics teams must continually adapt, embracing innovative tools and processes to keep pace.

The greatest value is achieved when advanced technology is combined with experienced operational and customer care teams that can interpret data, assess risks, and take decisive action. Together, scalable technology and human expertise enable organisations to manage complexity efficiently, support sustainable growth, and ensure critical therapies reach patients exactly when they are needed.

Reliability as a strategic advantage

Increasingly, reliability is becoming a strategic differentiator, rather than simply an operational requirement.

Reliable supply chains protect product quality, support regulatory compliance, and contribute directly to positive patient outcomes. At the same time, growing concerns around supply chain resilience have elevated logistics performance to a board-level consideration for many organisations.

As therapies become more specialised and global supply chains continue to expand, organisations are seeking partners and processes that provide visibility, expertise, and proactive risk management. The focus is shifting from the success of individual shipments to the long-term resilience of the entire supply chain ecosystem.

Looking beyond delivery

Reliability in life sciences logistics is no longer defined solely by whether a shipment arrives on time. It encompasses visibility, compliance, communication, risk management, and the ability to maintain continuity in an increasingly complex operating environment.

As advanced therapies, global supply networks, and regulatory expectations continue to evolve, organisations may need to look beyond traditional performance measures when assessing logistics capability. By balancing efficiency with resilience and combining technology with specialist expertise, the industry can build stronger, more reliable supply chains that protect product integrity and ultimately support better outcomes for patients.

About the author

Ryan Levesque is senior director, US operations at Biocair, where he leads operational excellence across the company's US network, supporting the safe and compliant transportation of critical life sciences materials worldwide. With extensive experience in pharmaceutical and healthcare logistics, Levesque specialises in building resilient supply chain solutions for biopharmaceutical, clinical trial, and advanced therapy customers.